The influence of physostigmine on respiratory and circulatory changes caused by overdoses of orphenadrine or imipramine in the rat.

Orphenadrine or imipramine were given intravenously as an infusion to spontaneously breathing, anaesthetized rats until respiratory arrest, the primary cause of death for both drugs. Intravenous injections of physostigmine did not prolong survival. Artificial ventilation prolonged survival for orphenadrine and imipramine by about a factor 3 and the rats died from cardiogenic shock. The cardiotoxic properties of orphenadrine and imipramine express themselves as a progressing disturbance in stimulus formation and conduction, a decrease in dP/dt max and increase in left ventricular end-diastolic pressure and a decrease in cardiac output caused by the progressing decrease of heart rate. An intravenous injection of physostigmine did not prolong survival and had no favourable effect on the cardiotoxicity caused by orphenadrine and imipramine. Although physostigmine may be useful in the treatment of the anticholinergic syndrome it has, at least in the rat, no favourable effect on the respiratory insufficiency, due to overdoses of orphenadrine and imipramine. Moreover it is not effective in antagonizing the cardiotoxic effects of orphenadrine or imipramine.
AuthorsP Zandberg, B Sangster
JournalActa pharmacologica et toxicologica (Acta Pharmacol Toxicol (Copenh)) Vol. 50 Issue 3 Pg. 185-95 (Mar 1982) ISSN: 0001-6683 [Print] DENMARK
PMID7090842 (Publication Type: Journal Article)
Chemical References
  • Physostigmine
  • Orphenadrine
  • Imipramine
  • Animals
  • Blood Gas Analysis
  • Blood Pressure (drug effects)
  • Cardiac Output (drug effects)
  • Electrocardiography
  • Hemodynamics (drug effects)
  • Imipramine (poisoning)
  • Male
  • Orphenadrine (poisoning)
  • Physostigmine (therapeutic use)
  • Rats
  • Respiration (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: